

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.40888342 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.60065180 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.60065180 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.60065180 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.60065180 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.60065180 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.60065180 |
| 8 | response to peptidoglycan (GO:0032494) | 5.42542787 |
| 9 | leukocyte aggregation (GO:0070486) | 5.30699780 |
| 10 | respiratory burst (GO:0045730) | 5.18801037 |
| 11 | neutrophil activation (GO:0042119) | 4.94692858 |
| 12 | superoxide anion generation (GO:0042554) | 4.84272978 |
| 13 | cellular extravasation (GO:0045123) | 4.83456732 |
| 14 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.77725253 |
| 15 | granulocyte activation (GO:0036230) | 4.73366973 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.69324246 |
| 17 | positive regulation of mast cell activation (GO:0033005) | 4.60504046 |
| 18 | positive regulation of mast cell degranulation (GO:0043306) | 4.50638343 |
| 19 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.50638343 |
| 20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49610897 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.46177514 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 4.45567327 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.43011530 |
| 24 | response to host immune response (GO:0052572) | 4.43011530 |
| 25 | detection of other organism (GO:0098543) | 4.36096862 |
| 26 | neutrophil mediated immunity (GO:0002446) | 4.35370776 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.34983517 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.34042513 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 4.28394589 |
| 30 | regulation of mast cell activation (GO:0033003) | 4.21796709 |
| 31 | response to interleukin-15 (GO:0070672) | 4.17602204 |
| 32 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.16809127 |
| 33 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.16494565 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 4.15729714 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07525116 |
| 36 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.01306514 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.97774576 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95909871 |
| 39 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.93455367 |
| 40 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.90142970 |
| 41 | response to host (GO:0075136) | 3.90142970 |
| 42 | response to host defenses (GO:0052200) | 3.90142970 |
| 43 | negative regulation of mast cell activation (GO:0033004) | 3.88215363 |
| 44 | microglial cell activation (GO:0001774) | 3.81321914 |
| 45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.81150534 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.78011385 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.77183753 |
| 48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.73811950 |
| 49 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.70936096 |
| 50 | detection of bacterium (GO:0016045) | 3.70088570 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68874490 |
| 52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65168425 |
| 53 | regulation of leukocyte degranulation (GO:0043300) | 3.59990542 |
| 54 | neutrophil chemotaxis (GO:0030593) | 3.59855927 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.57699527 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 3.56711566 |
| 57 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.56514489 |
| 58 | mast cell activation (GO:0045576) | 3.54420941 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.54003397 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.53556269 |
| 61 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.51473133 |
| 62 | phagosome maturation (GO:0090382) | 3.50489274 |
| 63 | neutrophil migration (GO:1990266) | 3.49140129 |
| 64 | macrophage activation (GO:0042116) | 3.48083284 |
| 65 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.44917266 |
| 66 | B cell mediated immunity (GO:0019724) | 3.40581837 |
| 67 | detection of external biotic stimulus (GO:0098581) | 3.38490893 |
| 68 | response to muramyl dipeptide (GO:0032495) | 3.35878952 |
| 69 | positive thymic T cell selection (GO:0045059) | 3.30750773 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.29844727 |
| 71 | positive regulation of interleukin-17 production (GO:0032740) | 3.29668087 |
| 72 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28270249 |
| 73 | negative thymic T cell selection (GO:0045060) | 3.27598788 |
| 74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27116873 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.26956661 |
| 76 | reactive oxygen species biosynthetic process (GO:1903409) | 3.26063278 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23104421 |
| 78 | tolerance induction (GO:0002507) | 3.23030732 |
| 79 | negative T cell selection (GO:0043383) | 3.22439336 |
| 80 | granulocyte chemotaxis (GO:0071621) | 3.19759124 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.19650349 |
| 82 | granulocyte migration (GO:0097530) | 3.16779804 |
| 83 | response to fungus (GO:0009620) | 3.15365691 |
| 84 | regulation of monocyte chemotaxis (GO:0090025) | 3.14940367 |
| 85 | positive regulation of leukocyte degranulation (GO:0043302) | 3.14484176 |
| 86 | negative regulation of interleukin-17 production (GO:0032700) | 3.12959437 |
| 87 | positive regulation of B cell differentiation (GO:0045579) | 3.11333931 |
| 88 | dendritic cell chemotaxis (GO:0002407) | 3.11167963 |
| 89 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.11005385 |
| 90 | leukotriene metabolic process (GO:0006691) | 3.10805800 |
| 91 | negative regulation of cell killing (GO:0031342) | 3.10376409 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10376409 |
| 93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.08493698 |
| 94 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.07451206 |
| 95 | B cell receptor signaling pathway (GO:0050853) | 3.06182039 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 3.04716912 |
| 97 | negative regulation of innate immune response (GO:0045824) | 3.04088491 |
| 98 | dendritic cell migration (GO:0036336) | 3.02895654 |
| 99 | regulation of tolerance induction (GO:0002643) | 3.02036145 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01704421 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 3.00613408 |
| 102 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.99535946 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 2.99124284 |
| 104 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98044625 |
| 105 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98044625 |
| 106 | detection of biotic stimulus (GO:0009595) | 2.97874803 |
| 107 | T-helper 1 type immune response (GO:0042088) | 2.97414000 |
| 108 | leukocyte mediated cytotoxicity (GO:0001909) | 2.97169686 |
| 109 | leukocyte degranulation (GO:0043299) | 2.96154883 |
| 110 | defense response to protozoan (GO:0042832) | 2.93819955 |
| 111 | positive regulation of interferon-alpha production (GO:0032727) | 2.93450955 |
| 112 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92409187 |
| 113 | I-kappaB phosphorylation (GO:0007252) | 2.91909590 |
| 114 | regulation of germinal center formation (GO:0002634) | 2.91491654 |
| 115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.91431230 |
| 116 | myeloid leukocyte activation (GO:0002274) | 2.91021969 |
| 117 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.90914300 |
| 118 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87950779 |
| 119 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.87887394 |
| 120 | regulation of regulated secretory pathway (GO:1903305) | 2.87743631 |
| 121 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87576177 |
| 122 | negative regulation of interleukin-1 production (GO:0032692) | 2.87477924 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.86245771 |
| 124 | positive regulation of acute inflammatory response (GO:0002675) | 2.84193537 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84069606 |
| 126 | eosinophil migration (GO:0072677) | 2.83478323 |
| 127 | regulation of T cell tolerance induction (GO:0002664) | 2.82353846 |
| 128 | lipoxygenase pathway (GO:0019372) | 2.80038706 |
| 129 | regulation of interferon-alpha production (GO:0032647) | 2.79204085 |
| 130 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.75420881 |
| 131 | regulation of interleukin-17 production (GO:0032660) | 2.71911098 |
| 132 | positive regulation of heat generation (GO:0031652) | 2.70695064 |
| 133 | superoxide metabolic process (GO:0006801) | 2.70320818 |
| 134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.65910543 |
| 135 | leukocyte cell-cell adhesion (GO:0007159) | 2.65102029 |
| 136 | leukocyte chemotaxis (GO:0030595) | 2.62977309 |
| 137 | regulation of activation of Janus kinase activity (GO:0010533) | 2.62024628 |
| 138 | positive regulation of interleukin-10 production (GO:0032733) | 2.60293113 |
| 139 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.59985897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.99202743 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.44785560 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69003204 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.58496954 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.42528791 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.28963728 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69156589 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59978334 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59315674 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.49931067 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41884295 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40855346 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.30776998 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.28627736 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23267800 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19607765 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14544053 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09370314 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07233202 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 1.96836113 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.90930439 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88123041 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85867678 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.82357107 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80142707 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78507921 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.76880058 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.73634468 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72660407 |
| 30 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70723562 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70481405 |
| 32 | MAF_26560356_Chip-Seq_TH2_Human | 1.70091077 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69009651 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68359357 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63473439 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.62749892 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62218637 |
| 38 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61176006 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60181412 |
| 40 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.59964460 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58392170 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.53364807 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52751973 |
| 44 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52407638 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52114225 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49223549 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47048921 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46106946 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40923821 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39976287 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39541402 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38699097 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35976170 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34444825 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33858832 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29725565 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29039516 |
| 58 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28994698 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27588686 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26107333 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25658303 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25317750 |
| 63 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24864143 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24502248 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23656666 |
| 66 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21950572 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20740287 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20659684 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20295372 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20047262 |
| 71 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.19642973 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19452575 |
| 73 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19239969 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19041494 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18459028 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18214049 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18038092 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17903610 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14659556 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14479734 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13601459 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13064472 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11797106 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11647923 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09803295 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07864878 |
| 87 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07857589 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07442093 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06399013 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06357137 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06190866 |
| 92 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06137527 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06049306 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05092556 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04812837 |
| 96 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.04792688 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04500997 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04370143 |
| 99 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04027138 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03990737 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03609479 |
| 102 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03158270 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02893236 |
| 104 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02525199 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01775310 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01481100 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01411127 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01247385 |
| 109 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01020204 |
| 110 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00293514 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98973370 |
| 112 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.98323999 |
| 113 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.98303261 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97572284 |
| 115 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97190407 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96455206 |
| 117 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96170580 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 0.96129259 |
| 119 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.95831204 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95415015 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94568740 |
| 122 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93821867 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93756409 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93231075 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92742097 |
| 126 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92417356 |
| 127 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.92389467 |
| 128 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91804593 |
| 129 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91734949 |
| 130 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89509299 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88534460 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88534460 |
| 133 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87679401 |
| 134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87323642 |
| 135 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.86289346 |
| 136 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.86250115 |
| 137 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.86083372 |
| 138 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85902706 |
| 139 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85214269 |
| 140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85186021 |
| 141 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.84851138 |
| 142 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84749322 |
| 143 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84709030 |
| 144 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.84174561 |
| 145 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83578371 |
| 146 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.82994879 |
| 147 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.82946395 |
| 148 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82690801 |
| 149 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.82667854 |
| 150 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81671293 |
| 151 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81461234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.15025007 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.97718690 |
| 3 | MP0002419_abnormal_innate_immunity | 3.50054936 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.38918572 |
| 5 | MP0009785_altered_susceptibility_to | 3.38202327 |
| 6 | MP0003303_peritoneal_inflammation | 3.28476856 |
| 7 | MP0003724_increased_susceptibility_to | 3.27760136 |
| 8 | * MP0005000_abnormal_immune_tolerance | 2.95996362 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.84327214 |
| 10 | MP0005025_abnormal_response_to | 2.78220598 |
| 11 | MP0005387_immune_system_phenotype | 2.58715350 |
| 12 | MP0001790_abnormal_immune_system | 2.58715350 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.57676259 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.52831037 |
| 15 | MP0006082_CNS_inflammation | 2.45504946 |
| 16 | MP0002277_abnormal_respiratory_mucosa | 2.42479392 |
| 17 | MP0001800_abnormal_humoral_immune | 2.36790411 |
| 18 | MP0004510_myositis | 2.30204612 |
| 19 | * MP0002723_abnormal_immune_serum | 2.28992975 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.26657305 |
| 21 | MP0009278_abnormal_bone_marrow | 2.24808400 |
| 22 | MP0005671_abnormal_response_to | 2.23047327 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.18822192 |
| 24 | MP0001819_abnormal_immune_cell | 2.17332518 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.16054705 |
| 26 | MP0008260_abnormal_autophagy | 2.11877740 |
| 27 | MP0003183_abnormal_peptide_metabolism | 2.10378322 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.10343919 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.03328935 |
| 30 | MP0002405_respiratory_system_inflammati | 2.02842135 |
| 31 | MP0003136_yellow_coat_color | 1.99413690 |
| 32 | MP0009764_decreased_sensitivity_to | 1.91986806 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.90178198 |
| 34 | MP0001853_heart_inflammation | 1.86914393 |
| 35 | MP0000015_abnormal_ear_pigmentation | 1.84776835 |
| 36 | MP0000343_altered_response_to | 1.77776363 |
| 37 | MP0000685_abnormal_immune_system | 1.69108961 |
| 38 | MP0005310_abnormal_salivary_gland | 1.68058452 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.65764179 |
| 40 | MP0004381_abnormal_hair_follicle | 1.64061692 |
| 41 | MP0003075_altered_response_to | 1.55476732 |
| 42 | MP0003866_abnormal_defecation | 1.52453260 |
| 43 | MP0003448_altered_tumor_morphology | 1.50659114 |
| 44 | MP0002933_joint_inflammation | 1.49220094 |
| 45 | MP0001851_eye_inflammation | 1.45228349 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.42864635 |
| 47 | MP0000716_abnormal_immune_system | 1.41924951 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.36496720 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.34871970 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.31855436 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.31197975 |
| 52 | MP0003690_abnormal_glial_cell | 1.29711222 |
| 53 | MP0003878_abnormal_ear_physiology | 1.29340306 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.29340306 |
| 55 | MP0002132_abnormal_respiratory_system | 1.27995706 |
| 56 | MP0008469_abnormal_protein_level | 1.26469802 |
| 57 | MP0003828_pulmonary_edema | 1.26425628 |
| 58 | MP0005409_darkened_coat_color | 1.23767070 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.23153081 |
| 60 | MP0004947_skin_inflammation | 1.21171878 |
| 61 | MP0002102_abnormal_ear_morphology | 1.20042902 |
| 62 | MP0000858_altered_metastatic_potential | 1.19512076 |
| 63 | MP0004742_abnormal_vestibular_system | 1.19389289 |
| 64 | MP0005164_abnormal_response_to | 1.18839846 |
| 65 | MP0004883_abnormal_blood_vessel | 1.17475750 |
| 66 | MP0002398_abnormal_bone_marrow | 1.17321791 |
| 67 | MP0005390_skeleton_phenotype | 1.16453275 |
| 68 | MP0005166_decreased_susceptibility_to | 1.16013301 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.13989321 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.13703687 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 1.10409727 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.09789961 |
| 73 | MP0002429_abnormal_blood_cell | 1.04281513 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.03970926 |
| 75 | MP0005083_abnormal_biliary_tract | 1.02071386 |
| 76 | MP0000689_abnormal_spleen_morphology | 0.98430518 |
| 77 | * MP0000920_abnormal_myelination | 0.98144436 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.98067881 |
| 79 | MP0005171_absent_coat_pigmentation | 0.97895688 |
| 80 | MP0005451_abnormal_body_composition | 0.92690265 |
| 81 | MP0002006_tumorigenesis | 0.92550624 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.89005948 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.89005948 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 0.88484403 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.88343699 |
| 86 | MP0002722_abnormal_immune_system | 0.87105939 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.85317391 |
| 88 | MP0002254_reproductive_system_inflammat | 0.82773900 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.82532791 |
| 90 | MP0001188_hyperpigmentation | 0.81055795 |
| 91 | MP0001873_stomach_inflammation | 0.80201538 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.77506227 |
| 93 | MP0008004_abnormal_stomach_pH | 0.76935106 |
| 94 | MP0001958_emphysema | 0.75147197 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.73896836 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.71930024 |
| 97 | MP0000604_amyloidosis | 0.69496836 |
| 98 | MP0001663_abnormal_digestive_system | 0.69440430 |
| 99 | MP0009840_abnormal_foam_cell | 0.67941093 |
| 100 | MP0003795_abnormal_bone_structure | 0.66348275 |
| 101 | MP0003045_fibrosis | 0.65279822 |
| 102 | MP0003950_abnormal_plasma_membrane | 0.63903868 |
| 103 | MP0009763_increased_sensitivity_to | 0.63225963 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.63083471 |
| 105 | MP0000371_diluted_coat_color | 0.62597652 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.62184140 |
| 107 | MP0000249_abnormal_blood_vessel | 0.61459530 |
| 108 | MP0003252_abnormal_bile_duct | 0.59995592 |
| 109 | MP0005365_abnormal_bile_salt | 0.58664934 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.57663550 |
| 111 | MP0004130_abnormal_muscle_cell | 0.57261592 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.53266930 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.51394383 |
| 114 | MP0002133_abnormal_respiratory_system | 0.51376998 |
| 115 | MP0005388_respiratory_system_phenotype | 0.51376998 |
| 116 | MP0000609_abnormal_liver_physiology | 0.51217592 |
| 117 | MP0002735_abnormal_chemical_nociception | 0.50962429 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.50362311 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.50304245 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.49041911 |
| 121 | MP0009046_muscle_twitch | 0.48989899 |
| 122 | MP0000566_synostosis | 0.48552682 |
| 123 | MP0000490_abnormal_crypts_of | 0.47567388 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.47538291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.26414347 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.32272130 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.22595037 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.59945148 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.25004371 |
| 6 | Obstructive lung disease (HP:0006536) | 4.99246894 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 4.99246894 |
| 8 | Gingivitis (HP:0000230) | 4.70945580 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.70878353 |
| 10 | Stomatitis (HP:0010280) | 4.63930413 |
| 11 | Recurrent skin infections (HP:0001581) | 4.60238424 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.25016513 |
| 13 | Optic neuritis (HP:0100653) | 4.25016513 |
| 14 | Myositis (HP:0100614) | 4.21288106 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.12532596 |
| 16 | Orchitis (HP:0100796) | 4.09038183 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.93868482 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.85720687 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52618799 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52618799 |
| 21 | Prostate neoplasm (HP:0100787) | 3.51591972 |
| 22 | T lymphocytopenia (HP:0005403) | 3.43483148 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.26858669 |
| 24 | Meningitis (HP:0001287) | 3.22657409 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.17432468 |
| 26 | Recurrent pneumonia (HP:0006532) | 3.12714607 |
| 27 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.12399688 |
| 28 | Urticaria (HP:0001025) | 3.06024046 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04213815 |
| 30 | Cellulitis (HP:0100658) | 3.00013446 |
| 31 | Chest pain (HP:0100749) | 2.94080086 |
| 32 | Anorexia (HP:0002039) | 2.93738495 |
| 33 | Vasculitis (HP:0002633) | 2.90334715 |
| 34 | Abnormality of T cells (HP:0002843) | 2.82560128 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 2.82186021 |
| 36 | Amyloidosis (HP:0011034) | 2.81481469 |
| 37 | Cheilitis (HP:0100825) | 2.74492372 |
| 38 | Increased IgE level (HP:0003212) | 2.70873994 |
| 39 | Parakeratosis (HP:0001036) | 2.70575599 |
| 40 | Episodic fever (HP:0001954) | 2.63261496 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.60598672 |
| 42 | Periodontitis (HP:0000704) | 2.57578976 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.53425537 |
| 44 | Thick nail (HP:0001805) | 2.53315174 |
| 45 | Joint hemorrhage (HP:0005261) | 2.52960837 |
| 46 | Osteomyelitis (HP:0002754) | 2.50748750 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 2.49223611 |
| 48 | Axonal loss (HP:0003447) | 2.49023793 |
| 49 | Recurrent lower respiratory tract infections (HP:0002783) | 2.46444550 |
| 50 | Hemoptysis (HP:0002105) | 2.45758600 |
| 51 | Granulocytopenia (HP:0001913) | 2.44898807 |
| 52 | Vertigo (HP:0002321) | 2.43261835 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.41945019 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.41680191 |
| 55 | Loss of speech (HP:0002371) | 2.41507988 |
| 56 | Abnormality of the pleura (HP:0002103) | 2.41427312 |
| 57 | Hypochromic anemia (HP:0001931) | 2.39364118 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39088893 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39088893 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39088893 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.37157026 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.35126954 |
| 63 | Pustule (HP:0200039) | 2.34182882 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.33398751 |
| 65 | Polyneuropathy (HP:0001271) | 2.31821041 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.30221948 |
| 67 | Recurrent viral infections (HP:0004429) | 2.26521062 |
| 68 | Purpura (HP:0000979) | 2.23773127 |
| 69 | IgG deficiency (HP:0004315) | 2.23414562 |
| 70 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23144314 |
| 71 | Disinhibition (HP:0000734) | 2.21740138 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.21679993 |
| 73 | Combined immunodeficiency (HP:0005387) | 2.20959252 |
| 74 | Increased serum ferritin (HP:0003281) | 2.15518536 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.15225226 |
| 76 | Basal ganglia calcification (HP:0002135) | 2.13275194 |
| 77 | Gingival bleeding (HP:0000225) | 2.12788872 |
| 78 | Leukocytosis (HP:0001974) | 2.12426508 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.08114917 |
| 80 | Abnormality of the endocardium (HP:0004306) | 2.07309758 |
| 81 | White forelock (HP:0002211) | 2.04386802 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.02821171 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.02393687 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01979235 |
| 85 | Sepsis (HP:0100806) | 2.01175151 |
| 86 | Inflammation of the large intestine (HP:0002037) | 2.00459125 |
| 87 | Eosinophilia (HP:0001880) | 1.99896789 |
| 88 | Chronic otitis media (HP:0000389) | 1.99334787 |
| 89 | Joint swelling (HP:0001386) | 1.98810753 |
| 90 | Encephalitis (HP:0002383) | 1.98387271 |
| 91 | Abnormality of the pericardium (HP:0001697) | 1.97923260 |
| 92 | Dysostosis multiplex (HP:0000943) | 1.97861080 |
| 93 | Xerostomia (HP:0000217) | 1.96529257 |
| 94 | Amaurosis fugax (HP:0100576) | 1.94432755 |
| 95 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.93651707 |
| 96 | Fatigue (HP:0012378) | 1.93274801 |
| 97 | Epistaxis (HP:0000421) | 1.93156355 |
| 98 | Chromsome breakage (HP:0040012) | 1.91167549 |
| 99 | Glomerulonephritis (HP:0000099) | 1.90471547 |
| 100 | Menorrhagia (HP:0000132) | 1.89979651 |
| 101 | Lymphopenia (HP:0001888) | 1.89518020 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88844108 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 1.88487226 |
| 104 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88442812 |
| 105 | Bone pain (HP:0002653) | 1.88399623 |
| 106 | Prolonged bleeding time (HP:0003010) | 1.88130652 |
| 107 | Thrombophlebitis (HP:0004418) | 1.87503061 |
| 108 | Patchy hypopigmentation of hair (HP:0011365) | 1.87498651 |
| 109 | Alveolar cell carcinoma (HP:0006519) | 1.86135552 |
| 110 | Microcytic anemia (HP:0001935) | 1.85551653 |
| 111 | Absent/shortened dynein arms (HP:0200106) | 1.85253761 |
| 112 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.85253761 |
| 113 | Absent frontal sinuses (HP:0002688) | 1.85215438 |
| 114 | Peritonitis (HP:0002586) | 1.84924786 |
| 115 | Skin rash (HP:0000988) | 1.84486378 |
| 116 | Increased IgM level (HP:0003496) | 1.84053201 |
| 117 | Petechiae (HP:0000967) | 1.83510891 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.82037186 |
| 119 | Arterial thrombosis (HP:0004420) | 1.81644187 |
| 120 | Agammaglobulinemia (HP:0004432) | 1.78909954 |
| 121 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.77900345 |
| 122 | Aplasia cutis congenita (HP:0001057) | 1.76536629 |
| 123 | Keratitis (HP:0000491) | 1.75971202 |
| 124 | Recurrent corneal erosions (HP:0000495) | 1.75508450 |
| 125 | Pulmonary embolism (HP:0002204) | 1.74545360 |
| 126 | Colitis (HP:0002583) | 1.70446249 |
| 127 | Submucous cleft hard palate (HP:0000176) | 1.69649541 |
| 128 | Duplicated collecting system (HP:0000081) | 1.68668358 |
| 129 | Recurrent sinusitis (HP:0011108) | 1.67711311 |
| 130 | Gangrene (HP:0100758) | 1.65708208 |
| 131 | Gastrointestinal inflammation (HP:0004386) | 1.63266048 |
| 132 | Skin ulcer (HP:0200042) | 1.60904768 |
| 133 | Pulmonary artery stenosis (HP:0004415) | 1.60750945 |
| 134 | Agnosia (HP:0010524) | 1.59644590 |
| 135 | Prolonged neonatal jaundice (HP:0006579) | 1.59506351 |
| 136 | IgM deficiency (HP:0002850) | 1.59300060 |
| 137 | Septo-optic dysplasia (HP:0100842) | 1.59166780 |
| 138 | Glomerulopathy (HP:0100820) | 1.58550670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.76882918 |
| 2 | RIPK4 | 4.57635673 |
| 3 | IRAK4 | 4.06024074 |
| 4 | MAP3K14 | 3.31820143 |
| 5 | IRAK3 | 2.45913660 |
| 6 | FGR | 2.43635808 |
| 7 | TXK | 2.31365718 |
| 8 | MAP4K1 | 2.24562221 |
| 9 | FES | 2.17396133 |
| 10 | EPHB1 | 2.12003890 |
| 11 | CASK | 2.05149959 |
| 12 | CSK | 2.03946491 |
| 13 | KIT | 2.02119697 |
| 14 | CLK1 | 1.94554673 |
| 15 | PBK | 1.84286406 |
| 16 | TEC | 1.77043573 |
| 17 | TBK1 | 1.73362448 |
| 18 | YES1 | 1.63604646 |
| 19 | TYK2 | 1.62597354 |
| 20 | TESK2 | 1.60760856 |
| 21 | HCK | 1.57862860 |
| 22 | IKBKB | 1.57618011 |
| 23 | IKBKE | 1.57171070 |
| 24 | SIK2 | 1.52143488 |
| 25 | MAP3K13 | 1.51453119 |
| 26 | BTK | 1.51195382 |
| 27 | TAOK3 | 1.49106915 |
| 28 | BMPR2 | 1.44170114 |
| 29 | MAP3K3 | 1.42465211 |
| 30 | GRK7 | 1.37249661 |
| 31 | TAOK1 | 1.37175872 |
| 32 | SIK3 | 1.36777415 |
| 33 | MAP3K11 | 1.36463081 |
| 34 | LYN | 1.30922262 |
| 35 | TRPM7 | 1.24973466 |
| 36 | SYK | 1.24356168 |
| 37 | BCKDK | 1.21355905 |
| 38 | MAP2K2 | 1.11214686 |
| 39 | MARK3 | 1.05769575 |
| 40 | MAP3K12 | 1.05422748 |
| 41 | EIF2AK2 | 1.03737089 |
| 42 | ADRBK2 | 1.03019705 |
| 43 | STK10 | 1.01582633 |
| 44 | MST4 | 1.00887894 |
| 45 | GRK1 | 1.00113736 |
| 46 | LCK | 0.98925152 |
| 47 | JAK1 | 0.94630230 |
| 48 | CSF1R | 0.94454357 |
| 49 | TGFBR2 | 0.93670995 |
| 50 | MAP3K1 | 0.93638247 |
| 51 | ZAP70 | 0.91024108 |
| 52 | JAK3 | 0.90128117 |
| 53 | PKN1 | 0.87919988 |
| 54 | ITK | 0.86283409 |
| 55 | PDK1 | 0.84856118 |
| 56 | TAOK2 | 0.82523222 |
| 57 | MKNK2 | 0.80836463 |
| 58 | PRPF4B | 0.79955693 |
| 59 | PRKD2 | 0.78543978 |
| 60 | TNIK | 0.76878267 |
| 61 | IRAK1 | 0.75640790 |
| 62 | MAP2K3 | 0.75196161 |
| 63 | CAMK1D | 0.73145520 |
| 64 | INSRR | 0.72669492 |
| 65 | MARK2 | 0.68570100 |
| 66 | PRKCQ | 0.67238786 |
| 67 | MAP3K7 | 0.66537784 |
| 68 | ABL1 | 0.64768351 |
| 69 | KSR2 | 0.64247813 |
| 70 | CHUK | 0.64180219 |
| 71 | CAMK1G | 0.64130307 |
| 72 | PDPK1 | 0.63873632 |
| 73 | MATK | 0.63797177 |
| 74 | BMPR1B | 0.63305153 |
| 75 | KDR | 0.62911811 |
| 76 | NUAK1 | 0.61625380 |
| 77 | PRKCD | 0.61586558 |
| 78 | IRAK2 | 0.61016429 |
| 79 | PTK6 | 0.56210817 |
| 80 | TNK2 | 0.56101771 |
| 81 | ERBB3 | 0.55839801 |
| 82 | EPHA3 | 0.52602650 |
| 83 | MUSK | 0.51530529 |
| 84 | TLK1 | 0.50874839 |
| 85 | ABL2 | 0.50501084 |
| 86 | CDK9 | 0.49617267 |
| 87 | STK4 | 0.49611941 |
| 88 | PIK3CG | 0.48549757 |
| 89 | LRRK2 | 0.48155977 |
| 90 | NLK | 0.48021136 |
| 91 | * FYN | 0.47926049 |
| 92 | PIM1 | 0.46908765 |
| 93 | NEK6 | 0.46136263 |
| 94 | MAP3K6 | 0.43866751 |
| 95 | JAK2 | 0.43468071 |
| 96 | MAP3K5 | 0.42304917 |
| 97 | GRK6 | 0.42214326 |
| 98 | EGFR | 0.38928207 |
| 99 | DMPK | 0.38591941 |
| 100 | RPS6KA2 | 0.37548431 |
| 101 | PRKG2 | 0.37486492 |
| 102 | CDK19 | 0.36937881 |
| 103 | RPS6KA6 | 0.36687186 |
| 104 | RPS6KA1 | 0.34908597 |
| 105 | CDK6 | 0.34272820 |
| 106 | RPS6KC1 | 0.33128433 |
| 107 | RPS6KL1 | 0.33128433 |
| 108 | PIM2 | 0.33000192 |
| 109 | CDK4 | 0.32739471 |
| 110 | MAPK4 | 0.32491326 |
| 111 | DAPK2 | 0.32165901 |
| 112 | PRKG1 | 0.32046543 |
| 113 | ERN1 | 0.30700378 |
| 114 | RAF1 | 0.30566965 |
| 115 | MAPK7 | 0.30052170 |
| 116 | CDK3 | 0.29305056 |
| 117 | IGF1R | 0.27297969 |
| 118 | MAPK3 | 0.27214929 |
| 119 | MAPKAPK2 | 0.27069272 |
| 120 | PRKCE | 0.26821034 |
| 121 | PRKAA2 | 0.26651316 |
| 122 | NEK9 | 0.26142229 |
| 123 | STK11 | 0.26009197 |
| 124 | HIPK2 | 0.25773607 |
| 125 | CDC42BPA | 0.25650668 |
| 126 | PRKD1 | 0.25596131 |
| 127 | MKNK1 | 0.25427413 |
| 128 | MAP2K6 | 0.25106749 |
| 129 | INSR | 0.24203462 |
| 130 | MOS | 0.23717705 |
| 131 | SGK1 | 0.22673567 |
| 132 | MAPK13 | 0.22205103 |
| 133 | MAPK12 | 0.22054282 |
| 134 | SRC | 0.19296648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22170035 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.12202872 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.43688722 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38654503 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.34416873 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.33463113 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31529957 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23219611 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.19444070 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.09989546 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07776622 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 1.98790793 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98216242 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.95454619 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.92576116 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.71676883 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.71356424 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68437222 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66386120 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.64800245 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.59651148 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57497823 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57284959 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.57271309 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.57256052 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.56523120 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.55853413 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53354959 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51359683 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45907651 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45389286 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45387816 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43946353 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32063169 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29462481 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22231594 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22069973 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21813767 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.20383351 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.12983668 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11398155 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07675040 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03715304 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03113688 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02986345 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01611894 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99022149 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94110845 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.88492061 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 0.87923848 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87596078 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86231856 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84760682 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84358618 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83761969 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79927151 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78517198 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.78094148 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.77394694 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72919705 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70798300 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.70112200 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69105121 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67563213 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66578901 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66553494 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.63768874 |
| 68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63428207 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63086985 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62451445 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.62134813 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62126090 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61472726 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60729986 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58724605 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.57943476 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57077574 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55474646 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54766245 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52872161 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50303439 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49723736 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46977234 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46698260 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46471449 |
| 86 | Morphine addiction_Homo sapiens_hsa05032 | 0.45714206 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44744919 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43228789 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41267521 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40093735 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39734009 |
| 92 | Melanoma_Homo sapiens_hsa05218 | 0.39021305 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37795041 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37768106 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36901517 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36660373 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36120754 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33461671 |
| 99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32257234 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31831960 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31686608 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30749971 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30543622 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29388256 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.28658730 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.28234946 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28048346 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26806572 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25084519 |
| 110 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24185750 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23666058 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23521647 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23409959 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23280982 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23279166 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.23051107 |
| 117 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.22797264 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22770292 |
| 119 | Long-term depression_Homo sapiens_hsa04730 | 0.22762475 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22727727 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20516650 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19088976 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16463714 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14789307 |

